M. Thiverny et al. / Tetrahedron: Asymmetry 22 (2011) 1274–1281
1279
3022 reflections with I > 2
r
(I) and 361 parameters are R1 = 0.0643,
(2H, d, J = 8.2 Hz), 4.77 (1H, s), 4.76 (1H, s), 2.88 (3H, s), 2.33 (1H,
qq, J = 6.8, 7.2 Hz), 1.50 (3H, s), 1.15 (3H, d, J = 6.8 Hz), 1.12 (3H,
d, J = 7.2 Hz); dC (100 MHz; CDCl3) 169.0, 137.5, 136.7, 130.9,
94.0, 84.9, 70.5, 35.1, 27.1, 22.9, 18.9, 18.5; LRMS (ESI+) m/z:
375.1 (45, (M+H)+), 397.1 (79, (M+Na)+), 749.0 (3, (2M+H)+),
771.1 (100, (2M+Na)+); HRMS (ESI+) m/z: found, 397.03914
(M+Na); C14H19IN2O2Na requires 397.03834; Anal. C14H19IN2O2 re-
quires C, 44.94; H, 5.12; N, 7.49. Found: C, 45.05; H, 5.17; N, 7.56.
wR2 = 0.1008 and for all 3445 unique reflections R1 = 0.0702,
wR2 = 0.1033. The data have been deposited at the Cambridge Crys-
tallographic Data Centre (Reference No. CCDC 819593).
4.2.6. (2S,5S)-1-Hydroxy-2-isopropyl-5-(2-methoxy-phenyl)-2,3-
dimethyl-imidazolidin-4-one (+)-2e
The title compound was prepared as described for 2a except
that the solution of nitrone (S)-1 (255 mg, 1.50 mmol) in THF
(3 mL) was added to the organomagnesium reagent obtained from
4.2.10. (2R,5R)-5-(4-Bromo-phenyl)-1-hydroxy-2-isopropyl-2,3-
dimethyl-imidazolidin-4-one (ꢀ)-2i
method C. Yield: 72%; white solid, mp: 160 °C; ½a D25
¼ þ61:7 (c
ꢃ
1.04, acetone); Rf 0.55 (ethyl acetate); IR (ATR): 3391, 3018,
2968, 2838, 1666; dH (400 MHz; CDCl3) 7.30–7.25 (2H, m), 6.93
(1H, t, J = 7.0 Hz), 6.87 (1H, d, J = 8.0 Hz), 5.97 (1H, br s), 5.15 (1H,
s), 3.78 (3H, s), 2.83 (3H, s), 2.19 (1H, qq, J = 6.8, 7.2 Hz), 1.04
(3H, s), 1.03 (3H, d, J = 6.8 Hz), 0.99 (3H, d, J = 7.2 Hz); dC
(100 MHz; CDCl3) 170.2, 158.6, 132.1, 129.7, 124.2, 120.6, 111.1,
86.0, 66.5, 55.7, 34.9, 27.2, 20.2, 18.8, 18.4; LRMS (ESI+) m/z:
279.2 (100, (M+H)+), 301.2 (71, (M+Na)+), 579.3 (54, (2M+Na)+);
HRMS (ESI+) m/z: found, 301.15175 (M+Na); C15H22N2O3Na re-
quires 301.15226. Anal. C15H22N2O3 requires C, 64.73; H, 7.97; N,
10.07. Found: C, 65.05; H, 8.10; N, 10.08.
The title compound was prepared as described for 2a (organo-
magnesium reagent: method B). Yield: 52%; white solid, mp:
153 °C; ½a 2D5
¼ ꢀ106:9 (c 1.38, acetone); Rf 0.67 (ethyl acetate);
ꢃ
IR (thin film): 3336, 3054, 2985, 1693; dH (400 MHz; CDCl3) 7.49
(2H, d, J = 8.4 Hz), 7.25 (2H, d, J = 8.4 Hz), 4.79 (1H, s), 4.78 (1H,
s), 2.88 (3H, s), 2.33 (1H, qq, J = 6.8, 7.2 Hz), 1.50 (3H, s), 1.15
(3H, d, J = 6.8 Hz), 1.12 (3H, d, J = 7.2 Hz); dC (100 MHz; CDCl3)
168.9, 136.1, 131.6, 130.6, 122.3, 84.9, 70.5, 35.1, 27.2, 23.1, 18.9,
18.6; LRMS (ESI+) m/z: 327.1 (100, (M+H)+), 329.1 (92, (M+H)+),
349.1 (92, (M+Na)+), 351.1 (93, (M+Na)+), 655.1 (5, (2M+H)+),
677.1 (43, (2M+Na)+), 679.1 (20, (2M+Na)+); HRMS (ESI+) m/z:
found, 349.05286 and 351.05049 (M+Na); C14H19BrN2O2Na re-
quires 349.05221 and 351.05017.
4.2.7. (2R,5R)-5-(4-Dimethylamino-phenyl)-1-hydroxy-2-isoprop-
yl-2,3-dimethyl-imidazolidin-4-one (ꢀ)-2f
The title compound was prepared as described for 2a (organo-
magnesium reagent: method B). The resulting crude material was
purified by trituration in boiling ethyl acetate to yield hydroxyl-
4.2.11. (2R,5R)-1-Hydroxy-2-isopropyl-2,3-dimethyl-5-penta-
fluorophenyl-imidazolidin-4-one (+)-2k
The title compound was prepared as described for 2a except
that the solid nitrone (R)-1 (255 mg, 1.50 mmol) was added in
one portion to the solution of organomagnesium reagent obtained
from method D (2.0 equiv) cooled to ꢀ30 °C. Yield: 78%; white so-
amine (ꢀ)-2f (65%) as a beige solid. mp: 184 °C; ½a D25
¼ ꢀ111:3 (c
ꢃ
1.10, acetone); Rf 0.34 (ethyl acetate/cyclohexane—70:30); IR
(ATR): 3251, 3006, 2987, 2965, 2796, 1679; dH (400 MHz; CDCl3)
7.20 (2H, d, J = 8.8 Hz), 6.72 (2H, d, J = 8.8 Hz), 4.96 (1H, s), 4.74
(1H, s), 2.93 (6H, s), 2.88 (3H, s), 2.28 (1H, qq, J = 6.8, 7.2 Hz),
1.41 (3H, s), 1.11 (3H, d, J = 6.8 Hz), 1.08 (3H, d, J = 7.2 Hz); dC
(100 MHz; CDCl3) 170.3, 150.8, 130.2, 124.3, 112.8, 84.8, 70.7,
40.8, 35.1, 27.1, 22.2, 18.9, 18.6; LRMS (ESI+) m/z: 292.2 (100,
(M+H)+), 314.2 (14, (M+Na)+), 583.4 (9, (2M+H)+), 605.3 (13,
(2M+Na)+); Anal. C16H25N3O2 requires C, 65.96; H, 8.65; N, 14.43.
Found: C, 65.75; H, 8.97; N, 14.48.
lid, mp: 178 °C; ½a D25
¼ þ14:8 (c 0.94, acetone); Rf 0.22 (cyclohex-
ꢃ
ane/ethyl acetate—70:30); IR (thin film): 3331, 2976, 2985, 2938,
1693, 1003; dH (400 MHz; CDCl3) 5.21 (1H, s), 4.86 (1H, s), 2.92
(3H, s), 2.28 (1H, hept, J = 7.2 Hz), 1.49 (3H, s), 1.15 (3H, d,
J = 7.2 Hz), 1.10 (3H, d, J = 7.2 Hz); dC (100 MHz; CDCl3) 167.1,
146.4 (d, J = 190 Hz), 141.5 (d, J = 190 Hz), 137.6 (d, J = 187 Hz),
111.2, 86.3, 62.0, 35.3, 27.1, 22.2, 18.4, 18.2; dF (282 MHz; CDCl3)
ꢀ141.2 (br), ꢀ153.7 (tt, 4J = 2.3 Hz, 3J = 21.4 Hz), ꢀ162.4 (td,
5J = 8.1 Hz, 3J = 21.4 Hz); LRMS (ESI+) m/z: 339.1 (34, (M+H)+),
361.1 (100, (M+Na)+), 699.2 (20, (2M+Na)+); HRMS (ESI+) m/z:
found, 361.09507 (M+Na); C14H15F5N2O2Na requires 361.09459.
4.2.8. (2R,5R)-1-Hydroxy-2-isopropyl-2,3-dimethyl-5-thiophen-
2-yl-imidazolidin-4-one (ꢀ)-2g
The title compound was prepared as described for 2a (organo-
magnesium reagent: method B). Yield: 79%; pink solid, mp:
4.2.12. (2R,5R)-1-Hydroxy-5-(4-methoxycarbonylphenyl)-2-iso-
propyl-2,3-dimethylimidazolidin-4-one (ꢀ)-2l28
118 °C; ½a 2D5
¼ ꢀ64:9 (c 1.24, acetone); Rf 0.62 (ethyl acetate); IR
ꢃ
(thin film): 3338, 3111, 3067, 2963, 2933, 1688; dH (300 MHz;
CDCl3) 7.28 (1H, dd, J = 1.2, 5.1 Hz), 7.15 (1H, dd, J = 1.2, 3.5 Hz),
7.01 (1H, dd, J = 3.5, 5.1 Hz), 5.12 (1H, s), 4.97 (1H, s), 2.89 (3H,
s), 2.30 (1H, hept, J = 9.2 Hz), 1.49 (3H, s), 1.13 (3H, d, J = 9.2 Hz),
1.10 (3H, d, J = 9.2 Hz); dC (100 MHz; CDCl3) 168.5, 140.0, 127.3,
127.1, 125.7, 85.1, 66.8, 35.1, 27.2, 22.2, 18.8, 18.5; LRMS (ESI+)
m/z: 255.0 (25, (M+H)+), 277.1 (100, (M+Na)+), 293.0 (17,
(M+K)+), 531.2 (67, (2M+Na)+); HRMS (ESI+) m/z: found,
277.09861 (M+Na); C12H18N2O2SNa requires 277.09812; Anal.
The title compound was prepared as described for 2a except
that a solution of nitrone (R)-1 (340 mg, 2.0 mmol) in THF (3 mL)
was added to the solution of organomagnesium reagent obtained
from method D (1.1 equiv). Yield: 46%; white solid, mp: 162 °C;
½
a 2D5
ꢃ
¼ ꢀ82:9 (c 1.00, acetone); Rf 0.67 (ethyl acetate); IR (ATR):
3424, 2987, 2959, 1715, 1686; dH (400 MHz; CDCl3) 7.95 (2H, d,
J = 8.3 Hz), 7.43 (2H, d, J = 8.3 Hz), 5.69 (1H, s), 4.83 (1H, s), 3.89
(3H, s), 2.84 (3H, s), 2.32 (1H, hept, J = 7.1 Hz), 1.47 (3H, s), 1.13
(3H, d, J = 7.1 Hz), 1.10 (3H, d, J = 7.1 Hz); dC (100 MHz; CDCl3)
169.0, 167.2, 142.2, 129.6 (2C), 128.7, 84.9, 70.7, 52.2, 35.0, 27.1,
23.2, 18.9, 18.5; LRMS (ESI+) m/z: 307.1 (M+H)+, 329.1 (M+Na)+.
C12H18N2O2S requires C, 56.67; H, 7.14; N, 11.02. Found: C,
56.99; H, 7.44; N, 11.18.
4.2.9. (2R,5R)-1-Hydroxy-5-(4-iodo-phenyl)-2-isopropyl-2,3-di-
methyl-imidazolidin-4-one (ꢀ)-2h
4.2.13. (2R,5R)-1-Hydroxy-2,5-diisopropyl-2,3-dimethylimid-
azolidin-4-one (–)-2m
The title compound was prepared as described for 2a except
that the solid nitrone (R)-1 (255 mg, 1.50 mmol) was added in
one portion to the solution of organomagnesium reagent obtained
from method D (2.0 equiv) cooled to ꢀ30 °C. Yield: 89%; white so-
The title compound was prepared as described for 2a using
iPrMgClꢁLiCl (method A). Yield: 41%; white solid, mp: 126 °C;
½
a 2D5
ꢃ
¼ ꢀ1:7 (c 1.06, acetone); Rf 0.26 (cyclohexane/ethyl ace-
tate—60:40); IR (thin film): 3284, 2965, 2933, 1675; dH
(400 MHz; CDCl3) 4.69 (1H, s), 3.66 (1H, d, J = 3.6 Hz), 2.80 (3H,
s), 2.25 (1H, qq, J = 6.8, 7.2 Hz), 2.17–2.13 (1H, m), 1.41 (3H, s),
1.07 (3H, d, J = 6.8 Hz), 1.05 (3H, d, J = 6.8 Hz), 1.04 (3H, d,
lid, mp: 151 °C; ½a D25
¼ ꢀ104:8 (c 1.14, acetone); Rf 0.26 (cyclohex-
ꢃ
ane/ethyl acetate—60:40); IR (thin film): 3345, 3054, 2976, 2959,
2933, 1682; dH (400 MHz; CDCl3) 7.69 (2H, d, J = 8.2 Hz), 7.14